MLTX logo

MoonLake Immunotherapeutics (MLTX) Working Capital

Annual Working Capital:

$451.82M-$52.38M(-10.39%)
December 31, 2024

Summary

  • As of today, MLTX annual working capital is $451.82 million, with the most recent change of -$52.38 million (-10.39%) on December 31, 2024.
  • During the last 3 years, MLTX annual working capital has risen by +$463.28 million (+4045.76%).
  • MLTX annual working capital is now -10.39% below its all-time high of $504.20 million, reached on December 31, 2023.

Performance

MLTX Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLTXbalance sheet metrics

Quarterly Working Capital:

$428.12M-$54.16M(-11.23%)
June 30, 2025

Summary

  • As of today, MLTX quarterly working capital is $428.12 million, with the most recent change of -$54.16 million (-11.23%) on June 30, 2025.
  • Over the past year, MLTX quarterly working capital has dropped by -$96.48 million (-18.39%).
  • MLTX quarterly working capital is now -21.40% below its all-time high of $544.68 million, reached on March 31, 2024.

Performance

MLTX Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLTXbalance sheet metrics

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

MLTX Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-10.4%-18.4%
3Y3 Years+4045.8%+352.9%
5Y5 Years+10000.0%+10000.0%

MLTX Working Capital Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-10.4%+4045.8%-21.4%+622.9%
5Y5-Year-10.4%+4045.8%-21.4%+594.2%
All-TimeAll-Time-10.4%+4045.8%-21.4%+594.2%

MLTX Working Capital History

DateAnnualQuarterly
Jun 2025
-
$428.12M(-11.2%)
Mar 2025
-
$482.28M(+6.7%)
Dec 2024
$451.82M(-10.4%)
$451.82M(-8.2%)
Sep 2024
-
$492.24M(-6.2%)
Jun 2024
-
$524.60M(-3.7%)
Mar 2024
-
$544.68M(+8.0%)
Dec 2023
$504.20M(+632.4%)
$504.20M(+3.0%)
Sep 2023
-
$489.70M(-1.9%)
Jun 2023
-
$499.23M(+742.9%)
Mar 2023
-
$59.23M(-14.0%)
DateAnnualQuarterly
Dec 2022
$68.85M(+701.2%)
$68.85M(-16.6%)
Sep 2022
-
$82.52M(-12.7%)
Jun 2022
-
$94.52M(+209.1%)
Mar 2022
-
-$86.63M(-656.5%)
Dec 2021
-$11.45M(-866.6%)
-$11.45M(-1243.5%)
Sep 2021
-
-$852.30K(-168.7%)
Jun 2021
-
$1.24M(-11.3%)
Mar 2021
-
$1.40M(-6.3%)
Dec 2020
$1.49M
$1.49M(+1141.0%)
Sep 2020
-
-$143.50K

FAQ

  • What is MoonLake Immunotherapeutics annual working capital?
  • What is the all-time high annual working capital for MoonLake Immunotherapeutics?
  • What is MoonLake Immunotherapeutics annual working capital year-on-year change?
  • What is MoonLake Immunotherapeutics quarterly working capital?
  • What is the all-time high quarterly working capital for MoonLake Immunotherapeutics?
  • What is MoonLake Immunotherapeutics quarterly working capital year-on-year change?

What is MoonLake Immunotherapeutics annual working capital?

The current annual working capital of MLTX is $451.82M

What is the all-time high annual working capital for MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics all-time high annual working capital is $504.20M

What is MoonLake Immunotherapeutics annual working capital year-on-year change?

Over the past year, MLTX annual working capital has changed by -$52.38M (-10.39%)

What is MoonLake Immunotherapeutics quarterly working capital?

The current quarterly working capital of MLTX is $428.12M

What is the all-time high quarterly working capital for MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics all-time high quarterly working capital is $544.68M

What is MoonLake Immunotherapeutics quarterly working capital year-on-year change?

Over the past year, MLTX quarterly working capital has changed by -$96.48M (-18.39%)
On this page